Hostname: page-component-7bb8b95d7b-l4ctd Total loading time: 0 Render date: 2024-09-18T10:37:04.188Z Has data issue: false hasContentIssue false

Prevalence and the Shift in Age of Onset

Published online by Cambridge University Press:  07 November 2014

Melissa P. DelBello*
Affiliation:
Dr. DelBello is assistant professor of psychiatry and pediatrics in the Department of Psychiatry at the, University of Cincinnati MedicalCenter in Ohio

Extract

Bipolar disorder is presenting at a younger ageof onset. In the past, many children with bipolar disorder wereundiagnosed and ended up in juvenile detention centers. These childrenwere also often misdiagnosed with severe attention-deficit/hyperactivitydisorder (ADHD) or conduct disorder. In addition, an increasedprevalence rate of substance use disorders and possibly stimulantprescriptions may be responsible for the shift in age of onset ofbipolar disorder. The most compelling epidemiological observations havecome out of the Netherlands, where they typically treat ADHDbehaviorally rather than with stimulants. Childhood bipolar disorderremains unidentified in the Netherlands despite aggressive searching,whereas adolescent and adult bipolar disorder has been found in numberssimilar to those in the United States. This providescross-sectional epidemiological evidence that stimulants may be shiftingthe age of onset in patients who are presenting with potentiallyprodromal bipolar symptoms. Lastly, several researchers speculate thattrinucleotide repeats in the DNA (deoxyribonucleic acid) may beresponsible for so-called genetic anticipation phenomenon, by whichexpansion of trinucleotide repeats in successive generations may beshifting the age of onset to an earlier age. These are just some of themechanistic possibilities for why we are seeing a shift in the age ofonset of bipolar disorder.

Lewinsohn and colleagues found thatthe lifetime prevalence of adolescent bipolar I and II disorder is ~1%,with a 5% lifetime prevalence rate of subsyndromal bipolar disorder.Many symptomatic children and adolescents do not meet full durationcriteria for a hypomanic or manic episode, or they may be one symptomshort of meeting criteria for the disorder.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Wals, M, Hillegers, MH, Reichart, CG, Ormel, J, Nolen, WA, Verhulst, FC. Prevalence of psychopathology in children of a bipolar parent. J Am Acad Child Adolesc Psychiatry. 2001;9:10941102.CrossRefGoogle Scholar
2.Lewinsohn, PM, Klein, DN, Seeley, JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;2(3 Pt 2):281293.CrossRefGoogle Scholar
3.Geller, B, Zimerman, B, Williams, M, et al.DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol. 2002;12:1125.CrossRefGoogle Scholar
4.Geller, B, Warner, K, Williams, M, Zimerman, B. Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J Affect Disord. 1998;51:93100.CrossRefGoogle Scholar
5. Sachs, GS, Baldassano, CF, Truman, CJ, Guille, C. Comorbidity of attention deficit hyperactivity disorder with early-and late-onset bipolar disorder. Am J Psychiatry. 2000;3:466468.CrossRefGoogle Scholar
6.Strober, M, Schmidt-Lackner, S, Freeman, R, Bower, S, Lampert, C, DeAntonio, M. Recovery and relapse in adolescents with bipolar affective illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry. 1995;6:724731.CrossRefGoogle Scholar
7.Geller, B, Cooper, TB, Sun, K, et al.Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37:171178.CrossRefGoogle ScholarPubMed
8.Findling, RL, McNamara, NK, Gracious, BL, et al.Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry. 2003;42:895901.CrossRefGoogle ScholarPubMed
9.Kowatch, RA, Suppes, T, Carmody, TJ, et al.Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713720.CrossRefGoogle ScholarPubMed
10.Frazier, JA, Biederman, J, Tohen, M, et al.A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001;3:239250.CrossRefGoogle Scholar
11.DelBello, MP, Miller, AN, Warner, J, Rosenberg, HL, Strakowski, SM. Olanzapine treatment for adolescent bipolar disorder. Poster presented at: Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 2002; San Francisco, CA.Google Scholar
12.DelBello, MP, Schwiers, ML, Rosenberg, HL, Strakowski, SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:12161223.CrossRefGoogle ScholarPubMed
13.Frazier, JA, Meyer, MC, Biederman, J, et al.Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 1999;8:960965.CrossRefGoogle Scholar